Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Tagliabue

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|May 4, 2026
Pericardial Effusion After Cardiac Surgery: Prevalence, Characteristics, Risk Factors and ManagementGaia Cattadori, Anna Picozzi, Elena Tagliabue, et al.
Journal of Neuroimmunology|August 27, 2005
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitisBenedetta Mazzanti, Tiziana Biagioli, Alessandra Aldinucci, et al.
European Radiology|March 20, 2019
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patientsSarah Alessi, Paola Pricolo, Paul Summers, et al.
Panminerva Medica|April 8, 2025
Results of AIPO Italian survey on sustainability in Interventional PulmonologyFilippo Patrucco, Alberto Fantin, Alessandro Di Marco Berardino, et al.
Urologia Internationalis|April 6, 2016
Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS CriteriaGilberto Laurino Almeida, Giuseppe Petralia, Matteo Ferro, et al.
Cardiovascular Diabetology|February 27, 2019
Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2DLucia La Sala, Simona Mrakic-Sposta, Elena Tagliabue, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
Diabetes Care|May 3, 2020
MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34<sup>+</sup> Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb IschemiaGaia Spinetti, Elena Sangalli, Elena Tagliabue, et al.
Cellular and Molecular Life Sciences : CMLS|May 3, 2022
Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulinRosalba La Grotta, Paola de Candia, Fabiola Olivieri, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|May 4, 2026
Pericardial Effusion After Cardiac Surgery: Prevalence, Characteristics, Risk Factors and ManagementGaia Cattadori, Anna Picozzi, Elena Tagliabue, et al.
Journal of Neuroimmunology|August 27, 2005
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitisBenedetta Mazzanti, Tiziana Biagioli, Alessandra Aldinucci, et al.
European Radiology|March 20, 2019
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patientsSarah Alessi, Paola Pricolo, Paul Summers, et al.
Panminerva Medica|April 8, 2025
Results of AIPO Italian survey on sustainability in Interventional PulmonologyFilippo Patrucco, Alberto Fantin, Alessandro Di Marco Berardino, et al.
Urologia Internationalis|April 6, 2016
Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS CriteriaGilberto Laurino Almeida, Giuseppe Petralia, Matteo Ferro, et al.
Cardiovascular Diabetology|February 27, 2019
Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2DLucia La Sala, Simona Mrakic-Sposta, Elena Tagliabue, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
Diabetes Care|May 3, 2020
MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34<sup>+</sup> Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb IschemiaGaia Spinetti, Elena Sangalli, Elena Tagliabue, et al.
Cellular and Molecular Life Sciences : CMLS|May 3, 2022
Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulinRosalba La Grotta, Paola de Candia, Fabiola Olivieri, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Pageof 7